Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 24, Pages 15751
Publisher
MDPI AG
Online
2022-12-12
DOI
10.3390/ijms232415751
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TAMpepK Suppresses Metastasis through the Elimination of M2-Like Tumor-Associated Macrophages in Triple-Negative Breast Cancer
- (2022) Chanju Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combination of anti‐PD‐L1 antibody with peptide MEL‐dKLA targeting M2 tumor‐associated macrophages suppresses breast cancer metastasis
- (2022) Chanju Lee et al. Cancer Communications
- Therapeutic Effect of Melittin–dKLA Targeting Tumor-Associated Macrophages in Melanoma
- (2022) Ik-Hwan Han et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor-associated macrophages promote epithelial–mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling
- (2022) Xiangzhou Chen et al. Cell Communication and Signaling
- PEGylation improves the therapeutic potential of dimerized translationally controlled tumor protein blocking peptide in ovalbumin-induced mouse model of airway inflammation
- (2022) Hyeran Seo et al. DRUG DELIVERY
- Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets
- (2021) Yan Lv et al. OncoTargets and Therapy
- Melittin, a honeybee venom derived peptide for the treatment of chemotherapy-induced peripheral neuropathy
- (2021) Tenzin Tender et al. MEDICAL ONCOLOGY
- Macrophage Biology and Mechanisms of Immune Suppression in Breast Cancer
- (2021) Anita K. Mehta et al. Frontiers in Immunology
- Immune Checkpoint Inhibition for Triple-Negative Breast Cancer: Current Landscape and Future Perspectives
- (2021) Huimei Yi et al. Frontiers in Oncology
- Nanoparticles Targeting Innate Immune Cells in Tumor Microenvironment
- (2021) Hochung Jang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer
- (2020) K.G.K. Deepak et al. PHARMACOLOGICAL RESEARCH
- Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer
- (2020) Maria Gagliardi et al. Scientific Reports
- Targeting tumor-associated macrophages in head and neck squamous cell carcinoma
- (2020) Bolei Li et al. ORAL ONCOLOGY
- Triple‑negative breast cancer therapy: Current and future perspectives (Review)
- (2020) Kwang‑Ai Won et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Targeting tumor‑associated macrophages in the tumor microenvironment (Review)
- (2020) Kaiwen Zhou et al. Oncology Letters
- Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
- (2020) Irina Larionova et al. Frontiers in Oncology
- Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
- (2020) Javier Cortes et al. LANCET
- Targeting Tumor-Associated Macrophages in Cancer
- (2019) Paulina Pathria et al. TRENDS IN IMMUNOLOGY
- Macrophages and Metabolism in the Tumor Microenvironment
- (2019) Ilio Vitale et al. Cell Metabolism
- Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8+ T Cell-Derived Interferon-γ
- (2019) Chang Liu et al. IMMUNITY
- Nano-viscosimetry analysis of the membrane disrupting action of the bee venom peptide melittin
- (2019) Sara Pandidan et al. Scientific Reports
- Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide
- (2019) Chanju Lee et al. Journal for ImmunoTherapy of Cancer
- Unraveling triple-negative breast cancer tumor microenvironment heterogeneity: towards an optimized treatment approach
- (2019) Yacine Bareche et al. JNCI-Journal of the National Cancer Institute
- The membrane effects of melittin on gastric and colorectal cancer
- (2019) Caroline Soliman et al. PLoS One
- 3D-3-culture: A tool to unveil macrophage plasticity in the tumour microenvironment
- (2018) Sofia P. Rebelo et al. BIOMATERIALS
- Breast cancer lung metastasis: Molecular biology and therapeutic implications
- (2018) Liting Jin et al. CANCER BIOLOGY & THERAPY
- Anti-Tumor Effects of Melittin and Its Potential Applications in Clinic
- (2018) Can Lyu et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment
- (2018) Elisa Peranzoni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular details on the intermediate states of melittin action on a cell membrane
- (2018) Jiaojiao Liu et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Tumor-associated macrophages in breast cancer: Innocent bystander or important player?
- (2018) Si-Qi Qiu et al. CANCER TREATMENT REVIEWS
- Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer
- (2018) Jonas Steenbrugge et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Protein PEGylation for cancer therapy: bench to bedside
- (2018) Vijayalaxmi Gupta et al. Journal of Cell Communication and Signaling
- Melittin suppresses tumor progression by regulating tumor-associated macrophages in a Lewis lung carcinoma mouse model
- (2017) Chanju Lee et al. Oncotarget
- PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
- (2016) Jung Soo Suk et al. ADVANCED DRUG DELIVERY REVIEWS
- PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs
- (2016) Peter L. Turecek et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian Cancer
- (2015) K. E. Hew et al. CLINICAL CANCER RESEARCH
- What is the future of PEGylated therapies?
- (2015) Magdalena Swierczewska et al. EXPERT OPINION ON EMERGING DRUGS
- Site-Specific PEGylation of Therapeutic Proteins
- (2015) Jonathan Dozier et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway
- (2015) Sangmin Kim et al. Oncotarget
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- High-Infiltration of Tumor-Associated Macrophages Predicts Unfavorable Clinical Outcome for Node-Negative Breast Cancer
- (2013) Yue Zhang et al. PLoS One
- The dynamics of melittin-induced membrane permeability
- (2012) Gašper Kokot et al. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
- Differentiation and gene expression profile of tumor-associated macrophages
- (2012) Astrid Schmieder et al. SEMINARS IN CANCER BIOLOGY
- Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression
- (2011) Rui Wang et al. LUNG CANCER
- Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma
- (2011) L. Agemy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway
- (2011) Miran Jo et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Cytolytic peptide nanoparticles (‘NanoBees’) for cancer therapy
- (2011) Hua Pan et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- Emerging PEGylated drugs
- (2009) Jung Seok Kang et al. EXPERT OPINION ON EMERGING DRUGS
- Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth
- (2009) Neelesh R. Soman et al. JOURNAL OF CLINICAL INVESTIGATION
- On the Mechanism of Pore Formation by Melittin
- (2008) Geert van den Bogaart et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More